SCHEMBL5233389

SCHEMBL5233389

CC(C)(C)OC(=O)N1CCCN(c2ccc(OC(F)(F)F)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.56
LMNA P02545 3/20 0.56
ALDH1A1 P00352 2/20 0.56
GPR119 Q8TDV5 6/20 0.53
LIPE Q05469 1/20 0.53
KCNA5 P22460 1/20 0.52
PDK2 Q15119 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.51
NAMPT P43490 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CYP2C19 P33261 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CHRM4 P08173 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922515 0.95 LMNA (0.61) MAPTLMNAALDH1A1GPR119LIPE
SCHEMBL5233751 0.86 L3MBTL1 (0.66) MAPTLMNAALDH1A1GPR119SMN1; SMN2
SCHEMBL5231271 0.85 MAPT (0.67) MAPTLMNAALDH1A1GPR119PDK2
SCHEMBL5230610 0.85 ALDH1A1 (0.61) MAPTLMNAALDH1A1GPR119PDK2
SCHEMBL3938884 0.84 MAPT (0.57) MAPTLMNAALDH1A1GPR119LIPE
SCHEMBL5543519 0.84 GPR119 (0.55) MAPTLMNAALDH1A1GPR119LIPE
SCHEMBL31466222 0.84 CKS1B (0.45) MAPTLMNAALDH1A1GPR119LIPE
SCHEMBL5231173 0.83 GPR119 (0.70) MAPTLMNAALDH1A1GPR119PDK2
SCHEMBL13281422 0.83 MAPT (0.62) MAPTLMNAALDH1A1GPR119PDK2
SCHEMBL5233944 0.83 MAPT (0.56) MAPTLMNAALDH1A1GPR119SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219234-A1 Thienopyridine Derivatives SANKYO COMPANY, LIMITED (JP) 2007-09-20 US disclosed
EP-1764367-A1 THIENOPYRIDINE DERIVATIVES Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219234-A1 Thienopyridine Derivatives RASGRP1, NRAS, HRH3 MAPT 4452/4885LMNA 4549/4885ALDH1A1 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.